Stocktoria
Pharma Mar, S.A. PHM.MC
Pharma Mar, S.A. statistics & valuation
Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
P / E vs its own history
Pharma Mar, S.A. trades at about 17.6× earnings — below its 10-year norm (10-year range 18.4×–646×, median 62.2×).
Shaded band = 10-year range (18.4×–646×); dot = today's 17.6×.
Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Gross margin | 94.5% | 95.3% | 93.9% | 93.1% |
| Operating margin | 27.1% | 3.4% | -2.5% | 22.6% |
| Net margin | 33.9% | 14.9% | 0.7% | 25.1% |
| FCF margin | 19.8% | -5.4% | -18.6% | 15.0% |
| Return on assets | 19.0% | 7.5% | 0.3% | 12.6% |
| Return on equity | 29.8% | 12.5% | 0.6% | 22.1% |
| Debt / equity | 0.14× | 0.19× | 0.14× | 0.12× |
| Current ratio | 3.02 | 3.03 | 2.63 | 2.83 |
Computed from company filings · ES · as of 2025-12-31. Figures in EUR. Facts plus Stocktoria's own computed scores — not investment advice.